Cesca Therapeutics Offers a Highly Speculative Opportunity by Joshua Enomoto | Technical AnalysisThe biotechnology industry is a sector that lives by its own rules. You can forget about fundamental analysis — investors either don’t know or don’t care. No matter how great or how terrible a biotech firm’s financials are, there’s a...